After PKA treatment, TnI and MyBP-C became phosphorylated to the levels of donor hearts and the difference in EC50 between a donor heart and heart with cardiomyopathy was ether fully eliminated or substantially reduced (Figure 3B,D). The gene discussed is MYBPC3; the disease is cardiomyopathy.